Abstract

Simple SummaryA non-integrating and self-replicating Venezuelan equine encephalitis RNA replicon system can potentially make a great contribution to the generation of clinically applicable canine induced pluripotent stem cells. Our study shows a new method to utilize the synthetic RNA-based approach for canine somatic cell reprogramming regarding transfection and reprogramming efficiency.Canine induced pluripotent stem cells (ciPSCs) can provide great potential for regenerative veterinary medicine. Several reports have described the generation of canine somatic cell-derived iPSCs; however, none have described the canine somatic cell reprogramming using a non-integrating and self-replicating RNA transfection method. The purpose of this study was to investigate the optimal strategy using this approach and characterize the transition stage of ciPSCs. In this study, fibroblasts obtained from a 13-year-old dog were reprogrammed using a non-integrating Venezuelan equine encephalitis (VEE) RNA virus replicon, which has four reprogramming factors (collectively referred to as T7-VEE-OKS-iG and comprised of hOct4, hKlf4, hSox2, and hGlis1) and co-transfected with the T7-VEE-OKS-iG RNA and B18R mRNA for 4 h. One day after the final transfection, the cells were selected with puromycin (0.5 µg/mL) until day 10. After about 25 days, putative ciPSC colonies were identified showing TRA-1-60 expression and alkaline phosphatase activity. To determine the optimal culture conditions, the basic fibroblast growth factor in the culture medium was replaced with a modified medium supplemented with murine leukemia inhibitory factor (mLIF) and two kinase inhibitors (2i), PD0325901(MEK1/2 inhibitor) and CHIR99021 (GSK3β inhibitor). The derived colonies showed resemblance to naïve iPSCs in their morphology (dome-shaped) and are dependent on mLIF and 2i condition to maintain an undifferentiated phenotype. The expression of endogenous pluripotency markers such as Oct4, Nanog, and Rex1 transcripts were confirmed, suggesting that induced ciPSCs were in the late intermediate stage of reprogramming. In conclusion, the non-integrating and self-replicating VEE RNA replicon system can potentially make a great contribution to the generation of clinically applicable ciPSCs, and the findings of this study suggest a new method to utilize the VEE RNA approach for canine somatic cell reprogramming.

Highlights

  • The derivation of induced pluripotent stem cells using four reprogramming factors known as Yamanaka’s factors (Oct4, Sox2, Klf4, and c-Myc) opens a new avenue for patient-specific regenerative medicine therapies [1,2,3]

  • The results of this study suggest that the Canine induced pluripotent stem cells (iPSCs) (ciPSCs) lines generated using RNA-based reprograming were in the late intermediate stage of reprogramming

  • We are the first group to report synthetic RNA-based reprogramming for ciPSCs from the fibroblasts of an old dog

Read more

Summary

Introduction

The derivation of induced pluripotent stem cells (iPSCs) using four reprogramming factors known as Yamanaka’s factors (Oct, Sox, Klf, and c-Myc) opens a new avenue for patient-specific regenerative medicine therapies [1,2,3]. The most representative companion animals, are very useful model for the development of new animal therapeutics such as gene and stem cell-based therapies [4,5,6]. Canine iPSCs (ciPSCs) show great potential for veterinary regenerative medicine and for translational medicine as a disease model [7,8]. It is important to note that the average age of companion dogs has increased in recent years, and that dogs share some disease-related genes with humans. Common canine diseases share similarities with human diseases, such as cancers, autoimmune diseases, and diabetes [12,13,14,15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.